Business Description
Clover Biopharmaceuticals Ltd
ISIN : KYG2280A1076
Compare
Compare
Traded in other countries / regions
02197.Hong Kong IPO Date
2021-11-05Description
Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.15 | |||||
| Equity-to-Asset | -0.46 | |||||
| Debt-to-Equity | -0.28 | |||||
| Debt-to-EBITDA | -0.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.73 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 64.9 | |||||
| 3-Year Book Growth Rate | 15 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 43.09 | |||||
| 9-Day RSI | 41.74 | |||||
| 14-Day RSI | 42.84 | |||||
| 6-1 Month Momentum % | -22.78 | |||||
| 12-1 Month Momentum % | -46.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.78 | |||||
| Quick Ratio | 0.44 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 23748.75 | |||||
| Days Sales Outstanding | 103.38 | |||||
| Days Payable | 6073.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 | |||||
| Shareholder Yield % | 37.21 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.01 | |||||
| Operating Margin % | -1705.12 | |||||
| Net Margin % | -3038.12 | |||||
| FCF Margin % | -1579.95 | |||||
| ROA % | -38.11 | |||||
| ROIC % | -23.28 | |||||
| ROC (Joel Greenblatt) % | -498.04 | |||||
| ROCE % | -988.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 0.3 | |||||
| PS Ratio | 11.6 | |||||
| EV-to-EBIT | -0.08 | |||||
| EV-to-Forward-EBIT | 0.02 | |||||
| EV-to-EBITDA | -0.09 | |||||
| EV-to-Forward-EBITDA | 0.01 | |||||
| EV-to-Revenue | 2.46 | |||||
| EV-to-FCF | -0.16 | |||||
| Earnings Yield (Greenblatt) % | -1250 | |||||
| FCF Yield % | -133.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clover Biopharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 31.782 | ||
| EPS (TTM) (HK$) | -0.775 | ||
| Beta | 3.1 | ||
| Volatility % | 58.76 | ||
| 14-Day RSI | 42.84 | ||
| 14-Day ATR (HK$) | 0.017123 | ||
| 20-Day SMA (HK$) | 0.28975 | ||
| 12-1 Month Momentum % | -46.49 | ||
| 52-Week Range (HK$) | 0.201 - 0.71 | ||
| Shares Outstanding (Mil) | 1,296.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clover Biopharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clover Biopharmaceuticals Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clover Biopharmaceuticals Ltd Frequently Asked Questions
What is Clover Biopharmaceuticals Ltd(HKSE:02197)'s stock price today?
The current price of HKSE:02197 is HK$0.28. The 52 week high of HKSE:02197 is HK$0.71 and 52 week low is HK$0.20.
When is next earnings date of Clover Biopharmaceuticals Ltd(HKSE:02197)?
The next earnings date of Clover Biopharmaceuticals Ltd(HKSE:02197) is 2025-03-26 Est..
Does Clover Biopharmaceuticals Ltd(HKSE:02197) pay dividends? If so, how much?
Clover Biopharmaceuticals Ltd(HKSE:02197) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers